Alkermes rebuffed by FDA on antidepressant - pharmaphorum

Submitted by Anonymous (not verified) on Mon, 02/04/2019 - 09:38

Alkermes rebuffed by FDA on antidepressant  pharmaphorumAlkermes is facing a significant delay for its ALKS 5461 candidate for major depressive disorder after the FDA turned down its marketing application.